{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:23:28Z","timestamp":1788985408097,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 82173437 and 82473543"],"award-info":[{"award-number":["NSFC 82173437 and 82473543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 82173437 and 82473543"],"award-info":[{"award-number":["NSFC 82173437 and 82473543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 82173437 and 82473543"],"award-info":[{"award-number":["NSFC 82173437 and 82473543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 82173437 and 82473543"],"award-info":[{"award-number":["NSFC 82173437 and 82473543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 82173437 and 82473543"],"award-info":[{"award-number":["NSFC 82173437 and 82473543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 82173437 and 82473543"],"award-info":[{"award-number":["NSFC 82173437 and 82473543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09649-y","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T17:27:24Z","timestamp":1749490044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Deucravacitinib as a monotherapy for concurrent management of psoriasis and chronic spontaneous urticaria"],"prefix":"10.1007","volume":"73","author":[{"given":"Xiaoying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bichun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"9649_CR1","doi-asserted-by":"publisher","unstructured":"Wh B, Mp S. Psoriasis. Lancet Lond Engl. 2015;386(9997). https:\/\/doi.org\/10.1016\/S0140-6736(14)61909-7","DOI":"10.1016\/S0140-6736(14)61909-7"},{"key":"9649_CR2","doi-asserted-by":"publisher","unstructured":"Leznoff AG, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol. 1989;84(1).   https:\/\/doi.org\/10.1016\/0091-6749(89)90180-2.","DOI":"10.1016\/0091-6749(89)90180-2"},{"key":"9649_CR3","doi-asserted-by":"publisher","unstructured":"Atwa MA, Emara AS, Youssef N, Bayoumy NM. Serum concentration of IL-17, IL-23 and TNF-\u03b1 among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test. J Eur Acad Dermatol Venereol:JEADV. 2014;28(4). https:\/\/doi.org\/10.1111\/jdv.12124","DOI":"10.1111\/jdv.12124"},{"key":"9649_CR4","doi-asserted-by":"publisher","unstructured":"Toubi E, Vadasz Z. The emerging role of IL-17 in the immune-pathogenesis of chronic spontaneous urticaria. ImmunoTargets Ther. 2020;9.  https:\/\/doi.org\/10.2147\/ITT.S266410","DOI":"10.2147\/ITT.S266410"},{"key":"9649_CR5","doi-asserted-by":"publisher","unstructured":"Da S, et al. Interleukin-17 is a potential player and treatment target in severe chronic spontaneous urticaria. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2020;50(7). https:\/\/doi.org\/10.1111\/cea.13616.","DOI":"10.1111\/cea.13616"},{"key":"9649_CR6","doi-asserted-by":"publisher","unstructured":"Brzewski P\u0141, et al. The role of focal infections in the pathogenesis of psoriasis and chronic urticaria. Postepy Dermatol Alergol. 2013;30(2).   https:\/\/doi.org\/10.5114\/pdia.2013.34155","DOI":"10.5114\/pdia.2013.34155"},{"key":"9649_CR7","doi-asserted-by":"publisher","unstructured":"Karstarli Bakay OS, Kacar N. Combined treatment with omalizumab and secukinumab in a patient with chronic spontaneous urticaria and psoriasis. Dermatol Ther. 2022;35(9).   https:\/\/doi.org\/10.1111\/dth.15638","DOI":"10.1111\/dth.15638"},{"key":"9649_CR8","doi-asserted-by":"publisher","unstructured":"Abdelmaksoud A, et al. Response of chronic refractory psoriasis vulgaris with urticaria to combined secukinumab and omalizumab: a case report and review of the literature. J Cosmet Dermatol. 2023;22(4).  https:\/\/doi.org\/10.1111\/jocd.15551","DOI":"10.1111\/jocd.15551"},{"issue":"17","key":"9649_CR9","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s40265-022-01796-y","volume":"82","author":"SM Hoy","year":"2022","unstructured":"Hoy SM. Deucravacitinib: first approval. Drugs. 2022;82(17):1671\u20139. https:\/\/doi.org\/10.1007\/s40265-022-01796-y.","journal-title":"Drugs"},{"issue":"5","key":"9649_CR10","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s13555-021-00596-8","volume":"11","author":"A Chimalakonda","year":"2021","unstructured":"Chimalakonda A, et al. Selectivity profile of the tyrosine kinase 2 inhibitor deucravacitinib compared with Janus kinase 1\/2\/3 inhibitors. Dermatol Ther. 2021;11(5):1763\u201376. https:\/\/doi.org\/10.1007\/s13555-021-00596-8.","journal-title":"Dermatol Ther"},{"issue":"3","key":"9649_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/bjd\/ljae406","volume":"192","author":"J Zhang","year":"2025","unstructured":"Zhang J, et al. Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial. Br J Dermatol. 2025;192(3):402\u20139. https:\/\/doi.org\/10.1093\/bjd\/ljae406.","journal-title":"Br J Dermatol"},{"key":"9649_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20553","author":"AW Armstrong","year":"2025","unstructured":"Armstrong AW, et al. Deucravacitinib in plaque psoriasis: four-year safety and efficacy results from the phase 3 POETYK PSO-1, PSO-2 and long-term extension trials. J Eur Acad Dermatol Venereol JEADV. 2025. https:\/\/doi.org\/10.1111\/jdv.20553.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"4","key":"9649_CR13","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3390\/ijms24043391","volume":"24","author":"L Rusi\u00f1ol","year":"2023","unstructured":"Rusi\u00f1ol L, Puig L. Tyk2 targeting in immune-mediated inflammatory diseases. Int J Mol Sci. 2023;24(4):3391. https:\/\/doi.org\/10.3390\/ijms24043391.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9649_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaad.2022.07.002","volume":"88","author":"AW Armstrong","year":"2023","unstructured":"Armstrong AW, et al. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial. J Am Acad Dermatol. 2023;88(1):29\u201339. https:\/\/doi.org\/10.1016\/j.jaad.2022.07.002.","journal-title":"J Am Acad Dermatol"},{"key":"9649_CR15","doi-asserted-by":"publisher","unstructured":"Ye D, et al. MRGPRX2 gain-of-function mutation drives enhanced mast cell reactivity in chronic spontaneous urticaria. J Allergy Clin Immunol. 2025;  S0091\u20136749(25)00305\u20137.  https:\/\/doi.org\/10.1016\/j.jaci.2025.03.007.","DOI":"10.1016\/j.jaci.2025.03.007"},{"issue":"11","key":"9649_CR16","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/ph17111499","volume":"17","author":"R Asero","year":"2024","unstructured":"Asero R, Calzari P, Vaienti S, Cugno M. Therapies for chronic spontaneous urticaria: present and future developments. Pharm Basel Switz. 2024;17(11):1499. https:\/\/doi.org\/10.3390\/ph17111499.","journal-title":"Pharm Basel Switz"},{"issue":"9","key":"9649_CR17","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.2741\/3908","volume":"16","author":"B Strobl","year":"2011","unstructured":"Strobl B, Stoiber D, Sexl V, Mueller M. Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity. Front Biosci Landmark Ed. 2011;16(9):3214\u201332. https:\/\/doi.org\/10.2741\/3908.","journal-title":"Front Biosci Landmark Ed"},{"issue":"5","key":"9649_CR18","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jaci.2023.12.008","volume":"153","author":"JA Bernstein","year":"2024","unstructured":"Bernstein JA, Maurer M, Saini SS. BTK signaling-a crucial link in the pathophysiology of chronic spontaneous urticaria. J Allergy Clin Immunol. 2024;153(5):1229\u201340. https:\/\/doi.org\/10.1016\/j.jaci.2023.12.008.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"9649_CR19","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s13555-023-00972-6","volume":"13","author":"G Yosipovitch","year":"2023","unstructured":"Yosipovitch G, Biazus Soares G, Mahmoud O. Current and emerging therapies for chronic spontaneous urticaria: a narrative review. Dermatol Ther. 2023;13(8):1647\u201360. https:\/\/doi.org\/10.1007\/s13555-023-00972-6.","journal-title":"Dermatol Ther"},{"issue":"4","key":"9649_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jaci.2021.08.009","volume":"148","author":"R Chovatiya","year":"2021","unstructured":"Chovatiya R, Paller AS. JAK inhibitors in the treatment of atopic dermatitis. J Allergy Clin Immunol. 2021;148(4):927\u201340. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.009.","journal-title":"J Allergy Clin Immunol"},{"key":"9649_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1068260","volume":"13","author":"I-H Huang","year":"2022","unstructured":"Huang I-H, Chung W-H, Wu P-C, Chen C-B. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review. Front Immunol. 2022;13: 1068260. https:\/\/doi.org\/10.3389\/fimmu.2022.1068260.","journal-title":"Front Immunol"},{"key":"9649_CR22","doi-asserted-by":"publisher","unstructured":"Mansouri P, Mozafari N, Chalangari R, Martits\u2010Chalangari K. Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis. Dermatol Ther. 2022;35(12):e15932. https:\/\/doi.org\/10.1111\/dth.15932","DOI":"10.1111\/dth.15932"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09649-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:29:02Z","timestamp":1770190142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09649-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9649"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09649-y","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"92"}}